(Q44437921)

3 December 2017

title

Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience (English)

1 reference

3 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00244-6

1 January 2024

author name string

E. Morelon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742467

1 January 2024

H. Kreis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742467

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0041134503002446?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00244-6

https://api.elsevier.com/content/article/PII:S0041134503002446?httpAccept=text/plain

1 January 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00244-6

Transplantation Proceedings

1 January 2024

published in

1 reference

3 December 2017

volume

35

1 reference

3 December 2017

issue

3 Suppl

1 reference

3 December 2017

page(s)

52S-57S

1 reference

Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Chronic cyclosporin nephropathy: long-term effects of cyclosporin on renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900244-6

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference